CANVAS-COVID Study Results

Results as of: July 14, 2021

Total persons enrolled in study

1 168 451

Vaccination dose received and survey completed:

DOSE 1

survey  completed

687,336

DOSE 2

survey  completed

123,402

People experiencing local reaction:

52%

Injection site pain/swelling/redness

Other health events that occurred after dose 1:

0%

8%

of people developed a new health event within 7 days of receiving their first dose

57,014 out of 687,336 doses

0%

5%

of people developed a new health event within 7 days that prevented daily activities/
work/required a medical visit

33,875 out of 687,336 doses

Other health events that occurred after dose 2:

0%

9%

of people developed a new health event within 7 days of receiving their second dose

11,023 out of 123,402 doses

0%

5%

of people developed a new health event within 7 days of receiving their second dose that prevented daily activities/work/required a medical visit

6,326 out of 123,402 doses

Most frequent other health events reported:

4.3%

Systemic symptoms

(fever, fatigue, muscle ache, feeling unwell)

3.1%

Headache or migraine

1.8%

Nausea, vomiting, diarrhea

Other events of interest:

Shingles is not occurring more frequently after vaccination

VACCINATED GROUP

0.02%

UNVACCINATED GROUP

0.03%